The global IBD treatment market is expanding due to biosimilars, with a projected CAGR of 4.5% from 2021 to 2026, driven by rising Crohn's disease cases and medical advancements.
The new report by Expert Market Research titled, ‘Global Inflammatory Bowel Disease Treatment Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global inflammatory bowel disease treatment market, assessing the market based on its segments like drug, disease, end-use, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/inflammatory-bowel-disease-treatment-market/requestsample
The key highlights of the report include:
Market Overview (2016-2026)
The global inflammatory bowel disease treatment market is expanding due to factors such as the rising prevalence of Crohn’s disease and ulcerative colitis, increased government funding for inflammatory bowel disease studies, and medical technology advancements. In addition, the growing popularity of pre-biotic and pro-biotic food products, as well as a rising number of drugs in clinical trials, are likely to contribute to market growth during the assessment period.
Industry Definition and Major Segments
IBD refers to a category of inflammatory disorders that affect the colon and small intestine. The two most common forms of inflammatory bowel disease are Crohn’s disease and ulcerative colitis. The treatment of the disease is known as inflammatory bowel disease treatment.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/inflammatory-bowel-disease-treatment-market
Based on drug, the market can be divided into:
Based on disease, the market is divided into:
The market can be categorised based on end-use into:
Regionally, the industry is classified into:
Market Trends
Rising demand for effective treatment has been driving the growth of the industry. Janssen Biotech Inc. and Protagonist Therapeutics Inc. signed a strategic agreement in 2017 to produce, manufacture, and market PTG-200, an oral IL 23 receptor for the treatment of inflammatory bowel disease. In another case, the European Union granted Pfizer Inc. marketing authorization for XELJANZ in 2018 for the treatment of moderate to serious ulcerative colitis.
Key Market Players
The major players in the market are Abbott Laboratories, Biocon Ltd., F. Hoffmann-La Roche Ag, Johnson & Johnson, Mylan Pharmaceuticals Ltd., Novartis Ag, Pfizer Inc., Quest Medical Inc., Sanofi S.A., and Takeda Pharmaceutical Company Ltd. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
About Us:
Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
Media Contact
Company Name: EMR Inc.
Contact Person:-Ian Bell, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States
Website: https://www.expertmarketresearch.com
Read More Reports:
Global Microencapsulation Market: https://www.expertmarketresearch.com/reports/microencapsulation-market
Global Anti-Infectives Market: https://www.expertmarketresearch.com/reports/anti-infectives-market
Global Liposomal Doxorubicin Market: https://www.expertmarketresearch.com/reports/liposomal-doxorubicin-market
Global Infertility Drugs Market: https://www.expertmarketresearch.com/reports/infertility-drugs-market
Global Contraceptive Drugs Market: https://www.expertmarketresearch.com/reports/contraceptive-drugs-market
Explore more on Procurement Intelligence services of EMR Inc.
Also visit: https://takeitcool.com/
**We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
The article discusses the growth of the global inflammatory bowel disease treatment market, driven by biosimilars.
Market growth is driven by biosimilars, rising Crohn's disease prevalence, government funding, and medical advancements.
Key players include Abbott Laboratories, Biocon Ltd., Pfizer Inc., and Takeda Pharmaceutical Company Ltd.
Explore more articles in the Research Reports category
